Xilio Therapeutics Stock (NASDAQ: XLO) stock price, news, charts, stock research, profile.
You can purchase shares of Xilio Therapeutics (NASDAQ:XLO) through any online brokerage.
Other companies in Xilio Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), OncoCyte (NASDAQ:OCX), Intensity Therapeutics (NASDAQ:INTS), Curis (NASDAQ:CRIS) and Precision BioSciences (NASDAQ:DTIL).
Xilio Therapeutics has a consensus price target of $7.00.
The stock price for Xilio Therapeutics (NASDAQ: XLO) is $0.8333 last updated January 24, 2025 at 7:33 AM EST.
There are no upcoming dividends for Xilio Therapeutics.
Xilio Therapeutics’s Q4 earnings are confirmed for Monday, March 31, 2025.
There is no upcoming split for Xilio Therapeutics.
Xilio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.